Donnelly Brian J's Form 4 filing
Myriad Genetics Inc (MYGN) · filed Sep 18, 2026
- Accession no.
- 0002065630-26-000008
- Filed
- Sep 18, 2026, 4:17 PM ET
- Rule 10b5-1 plan
- Not checked
This filing lists no transactions.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Donnelly Brian JCIK 0002065630 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
This "Exit" Form 4 is voluntarily filed to report solely that, effective on September 16, 2026, the Reporting Person no longer serves in the role of Chief Commercial Officer of the Company, and therefore is no longer subject to Section 16 reporting.